Skip to content
TrialScanner

NCT03287817

Cluster of Differentiation Antigen 19/22(CD19/22) CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma

Phase 1/Phase 2TerminatedAUTLLead

Registry record

Lead sponsor
Autolus Limited
Conditions
Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Primary completion
Oct 19, 2023Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03287817 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03287817: Cluster of Differentiation... | TrialScanner